Mersana Therapeutics Chief Medical Officer Arvin Yang receives $4.5M in 2020
Mersana Therapeutics reports 2020 executive compensation
By ExecPay News
Published: April 27, 2021
Mersana Therapeutics reported fiscal year 2020 executive compensation information on April 27, 2021.
In 2020, five executives at Mersana Therapeutics received on average a compensation package of $2.1M, a 91% increase compared to previous year.
Average pay of disclosed executives at Mersana Therapeutics
Arvin Yang, Chief Medical Officer, received $4.5M in total. 78% of Yang's compensation, or $3.5M, was in option awards. Yang also received $44K in salary and $943K in stock awards.
Anna Protopapas, Chief Executive Officer, received a compensation package of $2.5M, which increased by 46% compared to previous year. 48% of the compensation package, or $1.2M, was in option awards.
Timothy B. Lowinger, Chief Science and Technology Officer, earned $1.3M in 2020, a 54% increase compared to previous year.
Michael Kaufman, Chief Manufacturing Officer, received $1.2M in 2020, which increases by 41% compared to 2019.
Brian DeSchuytner, Senior Vice President, Finance & Product Strategy, earned $950K in 2020, a 6% increase compared to previous year.
Related executives
Anna Protopapas
Mersana Therapeutics
Chief Executive Officer
Brian DeSchuytner
Mersana Therapeutics
Chief Financial Officer
Michael Kaufman
Mersana Therapeutics
Former Chief Manufacturing Officer
Timothy Lowinger
Mersana Therapeutics
Senior Vice President, Chief Science and Technology Officer
Arvin Yang
Mersana Therapeutics
Chief Medical Officer
You may also like
Source: SEC filing on April 27, 2021.